Evidence map›Paper›PMID 29403488›Full record

ArticleFrontiers in immunology2018

Absence of Tumor Necrosis Factor Supports Alternative Activation of Macrophages in the Liver after Infection with

Shanshan Hu, Cameron Marshall, Jocelyn Darby, Wei Wei, Alan Bruce Lyons, Heinrich Körner

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
207.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 983 citations in OpenAlex.

  1. Frontiers in immunology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Leishmaniasis: Immune Cells Crosstalk in Macrophage Polarization.Tropical medicine and infectious disease · 2023
    Review
  11. Review
  12. Role of NETosis in Central Nervous System Injury.Oxidative medicine and cellular longevity · 2022
    Review
  13. Article
  14. Review
  15. Murine Susceptibility toFrontiers in cellular and infection microbiology · 2021
    Article
  16. Review
  17. Review
  18. Article
  19. Frontiers in cellular and infection microbiology · 2019
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Shanshan HuMenzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
Cameron MarshallMenzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
Jocelyn DarbyMenzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
Wei WeiInstitute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immunopharmacology, Ministry of Education, Engineering Technology Research Centre of Anti-Inflammatory and Immunodrugs in Anhui Province, Hefei, China.
Alan Bruce LyonsSchool of Medicine, University of Tasmania, Hobart, TAS, Australia.
Heinrich KörnerMenzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
University of Tasmania · AUMinistry of Education of the People's Republic of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The absence of tumor necrosis factor (TNF) causes lethal infection by

Indexed as

AnimalsArginaseCell DifferentiationCells, CulturedCytokine Receptor gp130InflammationInterleukin-4Interleukin-6Lectins, C-TypeLeishmania majorLeishmaniasis, CutaneousLiverMacrophage ActivationMacrophagesMannose-Binding LectinsMannose ReceptorArginaseCytokine Receptor gp130Interleukin-4Interleukin-6interleukin-6, mouseLectins, C-TypeMannose-Binding LectinsMannose ReceptorReceptor, Macrophage Colony-Stimulating FactorReceptors, Cell SurfaceStat3 protein, mouseSTAT3 Transcription FactorStat6 protein, mouseSTAT6 Transcription FactorTumor Necrosis Factor-alphaIL-6Leishmania majorlivermonocytestumor necrosis factor

Identifiers

PMID29403488
PMCPMC5780437
OpenAlexW2794045287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.